Peter D. Kwong
#104,893
Most Influential Person Now
Researcher
Peter D. Kwong's AcademicInfluence.com Rankings
Peter D. Kwongcomputer-science Degrees
Computer Science
#3808
World Rank
#4003
Historical Rank
Machine Learning
#557
World Rank
#564
Historical Rank
Artificial Intelligence
#760
World Rank
#772
Historical Rank
Database
#1082
World Rank
#1138
Historical Rank
Download Badge
Computer Science
Peter D. Kwong's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Peter D. Kwong Influential?
(Suggest an Edit or Addition)Peter D. Kwong's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody (1998) (3032)
- Antibody neutralization and escape by HIV-1 (2003) (2464)
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 (2010) (1653)
- The antigenic structure of the HIV gp120 envelope glycoprotein (1998) (1312)
- Structural basis of cell-cell adhesion by cadherins (1995) (1200)
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike (2020) (1122)
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 (2010) (1115)
- Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 (2021) (1071)
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 (2021) (1004)
- Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus (2013) (940)
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites (2002) (924)
- A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. (1998) (901)
- HIV vaccine design and the neutralizing antibody problem (2004) (835)
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 (2011) (827)
- Structural definition of a conserved neutralization epitope on HIV-1 gp120 (2007) (822)
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) (809)
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody (2012) (804)
- Structure of a V3-Containing HIV-1 gp120 Core (2005) (780)
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing (2011) (730)
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus (2013) (687)
- Structure and immune recognition of trimeric prefusion HIV-1 Env (2014) (682)
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies (2014) (675)
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody (2013) (619)
- The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 (2002) (570)
- Crystal structure of an HIV-binding recombinant fragment of human CD4 (1990) (520)
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection (2015) (501)
- Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope (2004) (492)
- Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization (2013) (474)
- Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. (2012) (469)
- Energetics of the HIV gp120-CD4 binding reaction. (2000) (462)
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2 (2012) (431)
- Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 (2007) (423)
- Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors (2011) (420)
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface (2014) (416)
- Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions (2014) (413)
- Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. (2000) (410)
- Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1 (2003) (384)
- Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. (2013) (381)
- Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G (2016) (355)
- Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite (2021) (352)
- Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility (2009) (351)
- Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization (2021) (333)
- Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning (2013) (324)
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes (2011) (319)
- Antigenic conservation and immunogenicity of the HIV coreceptor binding site (2005) (316)
- Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization (2021) (313)
- Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120 (2000) (310)
- Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. (2013) (308)
- Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 (2009) (307)
- Crystal structure, conformational fixation, and entry-related interactions of mature ligand-free HIV-1 Env (2015) (305)
- Highly Stable Trimers Formed by Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Fused with the Trimeric Motif of T4 Bacteriophage Fibritin (2002) (303)
- Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus (2000) (302)
- Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization (2021) (300)
- Elicitation of structure-specific antibodies by epitope scaffolds (2010) (292)
- Dimeric association and segmental variability in the structure of human CD4 (1997) (277)
- Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth. (2016) (276)
- Evaluation of candidate vaccine approaches for MERS-CoV (2015) (275)
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera (2015) (275)
- Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. (2004) (267)
- Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 (2013) (267)
- Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors (2015) (260)
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody (2016) (260)
- Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies (2014) (259)
- Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody (2016) (259)
- AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges (2015) (254)
- Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo (2014) (243)
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses (2016) (241)
- HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure. (2018) (239)
- Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination (2016) (236)
- Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops (2012) (235)
- Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains (2020) (235)
- Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 (2010) (232)
- Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor (2014) (228)
- Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold (2011) (217)
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques (2017) (216)
- Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection (2015) (210)
- Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding (1990) (210)
- Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization (2013) (210)
- Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 (2018) (208)
- Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. (2010) (205)
- Tyrosine Sulfation of Human Antibodies Contributes to Recognition of the CCR5 Binding Region of HIV-1 gp120 (2003) (193)
- Mutagenic Stabilization and/or Disruption of a CD4-Bound State Reveals Distinct Conformations of the Human Immunodeficiency Virus Type 1 gp120 Envelope Glycoprotein (2002) (192)
- Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies (2015) (190)
- Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape (2012) (188)
- New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency (2015) (187)
- Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. (2003) (180)
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies (2021) (175)
- Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques (2016) (174)
- Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires (2016) (173)
- A proof of concept for structure-based vaccine design targeting RSV in humans (2019) (170)
- The Rational Design of an AIDS Vaccine (2006) (166)
- Modifications That Stabilize Human Immunodeficiency Virus Envelope Glycoprotein Trimers in Solution (2000) (166)
- Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. (2011) (165)
- Structural basis of respiratory syncytial virus neutralization by motavizumab (2010) (162)
- Routine single particle CryoEM sample and grid characterization by tomography (2017) (162)
- Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design (2012) (161)
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (2018) (160)
- Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. (2008) (158)
- Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design (2015) (152)
- Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. (2017) (148)
- Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer (2016) (146)
- Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape (2018) (142)
- Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site (2015) (140)
- Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite (2018) (140)
- Mining the antibodyome for HIV-1–neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains (2013) (139)
- Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site (2009) (136)
- Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants (2021) (133)
- HIV-1 and influenza antibodies: seeing antigens in new ways (2009) (131)
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants (2021) (130)
- PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4 (2012) (130)
- Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity*♦ (2016) (128)
- Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization (2021) (126)
- Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET. (2019) (120)
- Characterization of Human Immunodeficiency Virus Type 1 Monomeric and Trimeric gp120 Glycoproteins Stabilized in the CD4-Bound State: Antigenicity, Biophysics, and Immunogenicity (2007) (117)
- Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of Vulnerability (2011) (116)
- Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region (2009) (115)
- Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies. (2014) (115)
- Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity (2010) (113)
- Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants (2021) (109)
- Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F (2010) (106)
- Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. (2011) (106)
- Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies (2013) (104)
- Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. (2005) (103)
- Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike (2020) (102)
- HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations (2018) (100)
- Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env (2015) (100)
- Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant (2011) (99)
- mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron (2022) (98)
- Mechanism of Human Immunodeficiency Virus Type 1 Resistance to Monoclonal Antibody b12 That Effectively Targets the Site of CD4 Attachment (2009) (96)
- Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection (2014) (94)
- Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. (1999) (94)
- Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection (2015) (93)
- Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies (2011) (92)
- Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection (2015) (92)
- Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization (2011) (91)
- Structure of beta 2-bungarotoxin: potassium channel binding by Kunitz modules and targeted phospholipase action. (1995) (91)
- Glycan Masking Focuses Immune Responses to the HIV‐1 CD4‐Binding Site and Enhances Elicitation of VRC01‐Class Precursor Antibodies (2018) (91)
- De novo identification of VRC01 class HIV-1–neutralizing antibodies by next-generation sequencing of B-cell transcripts (2013) (91)
- Considerations on the folding topology and evolutionary origin of cadherin domains. (1995) (91)
- Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge (2017) (90)
- Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 (2017) (89)
- Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline (2014) (87)
- Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models. (2017) (87)
- Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains. (2003) (86)
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV (2016) (85)
- Activation and lysis of human CD4 cells latently infected with HIV-1 (2015) (84)
- A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies (2012) (82)
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants (2022) (82)
- Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer (2017) (82)
- Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors. (2012) (81)
- Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization (2015) (81)
- Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist (2014) (79)
- Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth (2018) (78)
- Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies. (2016) (78)
- Soluble Mimetics of Human Immunodeficiency Virus Type 1 Viral Spikes Produced by Replacement of the Native Trimerization Domain with aHeterologous Trimerization Motif: Characterization and Ligand Binding Analysis (2005) (78)
- Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization (2019) (78)
- Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. (2010) (77)
- Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 (2021) (77)
- Enhancing protein crystallization through precipitant synergy. (2003) (77)
- Structural Basis for Broad Detection of Genogroup II Noroviruses by a Monoclonal Antibody That Binds to a Site Occluded in the Viral Particle (2012) (75)
- Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles (2020) (75)
- Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41 (2011) (74)
- Computational prediction of N-linked glycosylation incorporating structural properties and patterns (2012) (73)
- Design, synthesis, and antiviral activity of entry inhibitors that target the CD4-binding site of HIV-1. (2012) (72)
- Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide (2017) (72)
- Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma (2008) (72)
- A V3 Loop-Dependent gp120 Element Disrupted by CD4 Binding Stabilizes the Human Immunodeficiency Virus Envelope Glycoprotein Trimer (2010) (71)
- Preferential induction of cross-group influenza A hemagglutinin stem–specific memory B cells after H7N9 immunization in humans (2017) (70)
- Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1 (2017) (69)
- Structural Basis for Norovirus Inhibition and Fucose Mimicry by Citrate (2011) (69)
- PaRSnIP: sequence-based protein solubility prediction using gradient boosting machine (2018) (68)
- A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein (2018) (67)
- Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles (2020) (67)
- Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity (2017) (67)
- Somatic Populations of PGT135–137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics (2012) (66)
- Stapled HIV-1 Peptides Recapitulate Antigenic Structures and Engage Broadly Neutralizing Antibodies (2014) (66)
- Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening. (2011) (65)
- mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron (2022) (65)
- The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates (2021) (65)
- Virus‐like Particles Identify an HIV V1V2 Apex‐Binding Neutralizing Antibody that Lacks a Protruding Loop (2017) (64)
- Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection (2011) (62)
- Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral Strains (2013) (62)
- Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein (2008) (62)
- A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers. (2018) (61)
- Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition. (2019) (60)
- Progress in the rational design of an AIDS vaccine (2011) (59)
- Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation (2017) (59)
- The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions (2017) (59)
- Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design (2016) (59)
- The changing face of HIV vaccine research (2012) (59)
- Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate (2015) (59)
- Transitions to and from the CD4-Bound Conformation Are Modulated by a Single-Residue Change in the Human Immunodeficiency Virus Type 1 gp120 Inner Domain (2009) (59)
- Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination (2019) (59)
- A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice (2021) (58)
- Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting (2017) (58)
- A Neutralizing Antibody Recognizing Primarily N‐Linked Glycan Targets the Silent Face of the HIV Envelope (2018) (57)
- Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody (2015) (56)
- Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure (2018) (55)
- Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies (2011) (55)
- Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus. (2007) (54)
- Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. (2008) (54)
- Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. (1998) (54)
- Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens. (2018) (54)
- Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape (2017) (54)
- Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1 (2010) (53)
- Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity. (2015) (51)
- Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4 (2018) (51)
- Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class (2021) (50)
- Longitudinal Analysis Reveals Early Development of Three MPER‐Directed Neutralizing Antibody Lineages from an HIV‐1‐Infected Individual (2019) (49)
- Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier (2018) (49)
- A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone (2020) (48)
- Enhanced Exposure of the CD4-Binding Site to Neutralizing Antibodies by Structural Design of a Membrane-Anchored Human Immunodeficiency Virus Type 1 gp120 Domain (2009) (48)
- SONAR: A High-Throughput Pipeline for Inferring Antibody Ontogenies from Longitudinal Sequencing of B Cell Transcripts (2016) (48)
- Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (2016) (47)
- Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1 (2015) (46)
- Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains. (2017) (45)
- Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. (2019) (45)
- Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site (2014) (45)
- Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial (2015) (45)
- A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike (2020) (45)
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike (2020) (44)
- Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies (2019) (43)
- Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells. (2010) (42)
- Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6 (2013) (42)
- Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody (2018) (42)
- cAb-Rep: A Database of Curated Antibody Repertoires for Exploring antibody diversity and Predicting Antibody Prevalence (2019) (42)
- Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant. (2016) (41)
- N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function (2013) (41)
- Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8 (2016) (41)
- Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles (2020) (41)
- Crystal structure of a fully glycosylated HIV‐1 gp120 core reveals a stabilizing role for the glycan at Asn262 (2015) (41)
- Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (2020) (41)
- Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120. (2017) (41)
- Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies (2021) (41)
- A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus (2015) (40)
- Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV (2018) (39)
- Energetics of the HIV gp 120-CD 4 binding reaction (2000) (39)
- HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies (2019) (39)
- Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04 (2012) (39)
- Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield. (2017) (38)
- A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone (2020) (38)
- Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus (2017) (38)
- How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design (2017) (37)
- Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth (2020) (37)
- Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition. (2020) (37)
- HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth (2015) (37)
- Hyperglycosylated Stable Core Immunogens Designed To Present the CD4 Binding Site Are Preferentially Recognized by Broadly Neutralizing Antibodies (2014) (36)
- Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry (2019) (36)
- Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies (2017) (36)
- Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine (2019) (36)
- Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists (2007) (36)
- Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer. (2018) (35)
- Protection of calves by a prefusion-stabilized bovine RSV F vaccine (2017) (35)
- Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (2021) (35)
- Lineage-Specific Differences between Human and Simian Immunodeficiency Virus Regulation of gp120 Trimer Association and CD4 Binding (2012) (35)
- A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice (2021) (34)
- Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies (2021) (33)
- Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1. (2013) (32)
- Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates (2021) (32)
- Binding Mode Characterization of NBD Series CD4-Mimetic HIV-1 Entry Inhibitors by X-Ray Structure and Resistance Study (2014) (32)
- Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site. (2013) (32)
- Local Conformational Stability of HIV-1 gp120 in Unliganded and CD4-Bound States as Defined by Amide Hydrogen/Deuterium Exchange (2010) (32)
- Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry. (2008) (32)
- Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry. (2011) (31)
- Unprecedented Role of Hybrid N-Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies. (2018) (31)
- Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen (2020) (30)
- Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing Antibodies (2021) (30)
- Interfacial metal and antibody recognition. (2005) (30)
- HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies (2018) (29)
- Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies. (2016) (29)
- Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain (2021) (29)
- Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting (2019) (29)
- HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies (2018) (29)
- Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants (2021) (29)
- Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection (2016) (29)
- Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses (2020) (29)
- Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector (2016) (28)
- Human immunodeficiency virus: Refolding the envelope (2005) (28)
- Antibodyomics: bioinformatics technologies for understanding B‐cell immunity to HIV‐1 (2017) (28)
- Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry (2019) (27)
- Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site (2016) (27)
- Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations (2021) (27)
- Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate (2017) (26)
- Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies (2012) (26)
- Enhanced Exposure of the CD 4-Binding Site to Neutralizing Antibodies by Structural Design of a Membrane-Anchored Human Immunodeficiency Virus Type 1 gp 120 Domain (2009) (26)
- Heavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding Sites (2013) (25)
- CD4 Binding Site Antibodies Inhibit Human Immunodeficiency Virus gp120 Envelope Glycoprotein Interaction with CCR5 (2003) (24)
- What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist's Perspective. (2017) (24)
- Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus (2016) (24)
- The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T Cells (2015) (23)
- Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine (2016) (23)
- Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. (2021) (23)
- Improvement of antibody functionality by structure-guided paratope engraftment (2019) (23)
- Blocking α4β7 integrin binding to SIV does not improve virologic control (2019) (23)
- Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses. (2021) (22)
- Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein. (2013) (22)
- Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas (2015) (22)
- Mining the B cell repertoire for broadly neutralizing monoclonal antibodies to HIV-1. (2009) (22)
- Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core (2018) (22)
- Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape. (2018) (21)
- SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy (2022) (21)
- Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors (2018) (21)
- Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1* (2012) (21)
- Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (2020) (21)
- Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses (2021) (20)
- Antibody-guided structure-based vaccines. (2020) (20)
- Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates (2018) (20)
- High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19 (2021) (19)
- How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design. (2017) (19)
- Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains (2020) (19)
- Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains. (2020) (19)
- An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses (2022) (18)
- 147 Rational Design of Envelope Surface Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 (2011) (17)
- Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B (2019) (17)
- Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies (2019) (17)
- NEP: web server for epitope prediction based on antibody neutralization of viral strains with diverse sequences (2014) (16)
- Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain (2021) (16)
- Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses (2022) (16)
- HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY (1998) (15)
- Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates (2020) (15)
- CD4 receptor diversity in chimpanzees protects against SIV infection (2019) (15)
- Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F (2017) (14)
- Mammalian production of an isotopically enriched outer domain of the HIV-1 gp120 glycoprotein for NMR spectroscopy (2011) (14)
- Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes (2019) (14)
- VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage. (2020) (14)
- Does noggin head a new class of Kunitz domain? (1993) (13)
- A Single Shot Pre-fusion-Stabilized Bovine RSV F Vaccine is Safe and Effective in Newborn Calves with Maternally Derived Antibodies (2020) (13)
- Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses (2020) (13)
- Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria (2021) (12)
- High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19 (2021) (12)
- Mammalian expression of isotopically labeled proteins for NMR spectroscopy. (2012) (12)
- A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses (2021) (12)
- cAb-Rep: A Database of Curated Antibody Repertoires for Exploring Antibody Diversity and Predicting Antibody Prevalence (2019) (12)
- Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants (2021) (12)
- Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody (2021) (11)
- A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation. (2021) (11)
- Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies (2013) (11)
- Insights from NMR Spectroscopy into the Conformational Properties of Man‐9 and Its Recognition by Two HIV Binding Proteins (2017) (11)
- Eliminating antibody polyreactivity through addition of N‐linked glycosylation (2015) (11)
- Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses (2021) (10)
- Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature. (2020) (10)
- Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation (2018) (10)
- Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation. (2020) (10)
- Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies. (2021) (10)
- Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields. (2019) (9)
- Small-Molecule CD 4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp 120 (2018) (9)
- Structural aspects of CD4 and CD8 involvement in the cellular immune response. (1992) (9)
- Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates (2020) (9)
- N-terminal transmembrane-helix epitope tag for x-ray crystallography and electron microscopy of small membrane proteins. (2021) (9)
- Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron (2021) (8)
- Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses (2021) (8)
- Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability (2022) (8)
- Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120. (2017) (8)
- erratum: Antibody neutralization and escape by HIV-1 (2003) (8)
- Protective antibodies against human parainfluenza virus type 3 infection (2021) (8)
- Iterative screen optimization maximizes the efficiency of macromolecular crystallization (2019) (8)
- A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses (2021) (8)
- Erratum: Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer (2016) (8)
- Beta-bungarotoxin. Preparation and characterization of crystals suitable for structural analysis. (1989) (7)
- Design , synthesis and biological evaluation of small molecule inhibitors of CD 4-gp 120 binding based on virtual screening (2011) (7)
- Effective isotope labeling of proteins in a mammalian expression system. (2015) (6)
- CRYSTAL STRUCTURE OF AN /HIV$-BINDING FRAGMENT OF HUMAN /CD4$ (1991) (6)
- Blocking α4β7 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies (2021) (6)
- Virus-Like Particle Based-Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide (2020) (5)
- V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1 (2016) (5)
- Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage (2019) (5)
- The 447-52D antibody: hitting HIV-1 where its armor is thickest. (2004) (5)
- Selective effects of electrostatic changes in the CD4 CDR-3-like loop on infection by different human immunodeficiency virus type 1 isolates. (1996) (5)
- , Epitope 1 Antibody 2 F 5 in Complex with Its gp 41 Anti-Human Immunodeficiency Virus Type Structure and Mechanistic Analysis of the (2004) (5)
- Structural basis of malaria RIFIN binding by LILRB1-containing antibodies (2021) (5)
- Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformational Mobility (2009) (5)
- Single-Shot Vaccines against Bovine Respiratory Syncytial Virus (BRSV): Comparative Evaluation of Long-Term Protection after Immunization in the Presence of BRSV-Specific Maternal Antibodies (2021) (5)
- Vaccine Design Reaches the Atomic Level (2011) (5)
- Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core. (2018) (5)
- Crystal structure of Middle-East Respiratory Syndrome (MERS) coronavirus neutralizing antibody JC57-14 isolated from a vaccinated rhesus macaque. (2018) (5)
- Structure of the Core of the HIV-1 gp 120 Exterior Envelope Glycoprotein (1999) (5)
- A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination (2022) (5)
- Highly protective antimalarial antibodies via precision library generation and yeast display screening (2022) (4)
- Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies (2020) (4)
- Isolation and comparative analysis of antibodies that broadly neutralize sarbecoviruses (2021) (4)
- SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity (2021) (4)
- A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention (2021) (4)
- Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans (2020) (4)
- Corrigendum: Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer (2017) (4)
- Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (2019) (4)
- Kernel-based logistic regression model for protein sequence without vectorialization. (2015) (4)
- The Covalent SNAP Tag for Protein Display Quantification and Low-pH Protein Engineering. (2020) (4)
- Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron (2022) (3)
- Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide (2020) (3)
- A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins (2022) (3)
- Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement (2021) (3)
- A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite (2018) (3)
- Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base (2021) (3)
- Next‐generation sequencing of the intrahepatic antibody repertoire delineates a unique B‐cell response in HBV‐associated acute liver failure (2020) (3)
- Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies (2020) (3)
- Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes (2020) (3)
- Structural Biology and the Design of Effective Vaccines for HIV-1 and Other Viruses (2010) (3)
- Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency (2022) (3)
- Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite (2018) (3)
- Fab-dimerized glycan-reactive antibodies neutralize HIV and are prevalent in humans and rhesus macaques (2020) (3)
- Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains. Zhou et al. (2020) (3)
- Cryo-EM structures of prefusion SIV envelope trimer (2022) (3)
- HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B (2000) (2)
- Venom protection by antibody from a snakebite hyperimmune subject (2022) (2)
- Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site. (2022) (2)
- Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up) (2020) (2)
- Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces (2021) (2)
- A multispecific antibody confers pan-reactive SARS-CoV-2 neutralization and prevents immune escape (2022) (2)
- Structural survey of HIV-1-neutralizing antibodies targeting Env trimer delineates epitope categories and suggests vaccine templates (2018) (2)
- Publisher Correction: The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions (2018) (2)
- Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings (2022) (2)
- Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies (2021) (2)
- A Versatile Platform to Incorporate Viral Trimeric Antigens into Self-Assembling Nanoparticle Immunogens. (2020) (2)
- CRISPro: An Automated Pipeline for Protein Conformation Stabilization by Proline (2018) (2)
- Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (2016) (2)
- Structure of Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition (2019) (2)
- Structure-based Design of Trimeric V1V2 Antigens (2014) (2)
- D-103 Conformational dynamics of single HIV-1 Env trimers on the surface of native virions (2014) (2)
- Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. (2022) (2)
- Structure of the RSV F protein in the post-fusion conformation (2011) (1)
- Prefusion-Stabilized Lassa Virus Trimer Identifies Neutralizing Nanobodies and Reveals an Apex-Situated Site of Vulnerability (2022) (1)
- Single-Molecule FRET Delineates Asymmetric Trimer Conformations during HIV-1 Entry (2017) (1)
- Correction for Acharya et al., Heavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding Sites (2014) (1)
- Amarendra Pegu than those to the CD 4 receptor Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo (2014) (1)
- Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV‐2 (2021) (1)
- In Silico Improvement of Highly Protective Anti-Malarial Antibodies (2022) (1)
- Antibodies as drugs—a Keystone Symposia report (2022) (1)
- Crystal Structure of PG16 Fab in Complex with V1V2 Region from HIV-1 strain ZM109 (2011) (1)
- A multispecific antibody prevents immune escape and confers pan-SARS-CoV-2 neutralization (2022) (1)
- Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life (2022) (1)
- Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIVmac251 Acquisition (2023) (1)
- Vaccination Induces Maturation of Diverse Unmutated VRC01-Class Precursors to HIV-1 Broadly Neutralizing Antibodies in an Ig-Humanized Mouse Model (2020) (1)
- Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants. (2022) (1)
- STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM (1997) (1)
- Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants (2022) (1)
- Crystal structure of HIV-1 YU2 envelope gp120 glycoprotein in complex with CD4-mimetic miniprotein, M48U1, and llama single-domain, broadly neutralizing, co-receptor binding site antibody, JM4 (2013) (1)
- Correction: Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial (2016) (1)
- An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans (2023) (1)
- Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial (2022) (1)
- Structural Basis of Antibody Conformation and Stability Modulation by Framework Somatic Hypermutation (2022) (1)
- Antigenic analysis of the HIV-1 envelope trimer implies small differences between structural states 1 and 2 (2022) (1)
- HIV-1–Receptor Interactions (2010) (1)
- P-C4 Associating HIV-1 Env trimer structures with functional Env conformational states by smFRET analysis (2018) (1)
- Germline-targeting and Reverse Engineering to Elicit CH235.12 Lineage bNAbs (2018) (1)
- Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261 (2015) (0)
- Crystal structure of VRC46.01 Fab in complex with gp41 peptide (2019) (0)
- Cryo-EM Structure of CAP256-VRC26.25 Fab bound to HIV-1 Env trimer CAP256.wk34.c80 SOSIP.RnS2 (2020) (0)
- Crystal Structure of RSV-Neutralizing Human Antibody D25 (2013) (0)
- Cryo-EM structure of VRC01.23 in complex with HIV-1 Env BG505 DS.SOSIP (2021) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120 (2011) (0)
- HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b (2007) (0)
- Crystal structure of LAIR1 ectodomain (from MGD21) in complex with Plasmodium RIFIN (PF3D7_1040300) V2 domain (2021) (0)
- Publisher Correction: The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions (2018) (0)
- Crystal Structure of 10E8 Fab (2016) (0)
- Vaccine-elicited NHP FP-targeting neutralizing antibody DF1W-a.01 in complex with HIV fusion peptide (residue 512-519) (2019) (0)
- Consensus structure of SARS-CoV-2 spike at pH 5.5 (2020) (0)
- Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03 (2019) (0)
- D108 Synthetic HIV-1 Glycopeptides Enable Characterization of Fine Epitopes of Broadly Neutralizing Antibody PG9 (2013) (0)
- Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C2221 (2009) (0)
- ST102 Structural Basis for Broad and Potent HIV-1 neutralization by CD4-mimetic miniproteins (2013) (0)
- D-104 Structure, immune recognition, and conformational stabilization of the HIV-1 viral spike (2014) (0)
- Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120 (2014) (0)
- HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b (2007) (0)
- HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b (2007) (0)
- Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein (cid:1) † (2008) (0)
- Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 (2020) (0)
- Crystal structure of multidonor HV6-1-class broadly neutralizing Influenza A antibody 56.a.09 in complex with Hemagglutinin Hong Kong 1968. (2016) (0)
- Crystal structure of multidonor HV1-18+HD3-9 class broadly neutralizing Influenza A antibody 31.b.09 in complex with Hemagglutinin H1 A/California/04/2009 (2016) (0)
- Crystal structure of prefusion-stabilized bovine RSV F (DS-Cav1 variant: strain ATue51908) (2017) (0)
- Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 (2018) (0)
- Vaccine-elicited NHP FP-targeting neutralizing antibody A12V163-a.02 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- Structure of the Unliganded Fab from HIV-1 Neutralising Antibody CAP248-2B that Binds to the gp120 C-terminus - gp41 Interface (2016) (0)
- Abstracts of the HIV Research for Prevention Meeting, HIV R4P, 28–31 October, 2014, Cape Town, South Africa. (2014) (0)
- Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom (2019) (0)
- Crystal Structure of 101F Fab Bound to 15-mer Peptide Epitope (2010) (0)
- Conformational Dynamics of Single HIV Env Molecules on the Surface of Native Virions (2013) (0)
- Augmenting Neutralization breadth against Diverse HIV-1 by increasing the Ab-Ag interface on V2 (2021) (0)
- Structure of vaccine-elicited diverse HIV-1 neutralizing antibody vFP1.01 in complex with HIV-1 fusion peptide residue 512-519 (2018) (0)
- Insights into the Dynamics of the HIV-1 Env Glycan Shield (2017) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 gp120 (2010) (0)
- Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1 (2022) (0)
- Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with the HIV-1 surface protein (2013) (0)
- Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/E gp120 and sCD4. (2014) (0)
- 126 Broadly Neutralizing HIV Abs: Gains and Losses in Translation (2012) (0)
- Crystal Structure of P Domain from Norwalk Virus Strain Vietnam 026 in complex with Fucose (2011) (0)
- Potent vaccine sera target epitopes that overlap the CD4 binding site. (2015) (0)
- Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 (2019) (0)
- Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite. (2022) (0)
- Crystal structure of RV144-elicited antibody CH58 in complex with V2 peptide (2013) (0)
- Crystal structure of a motavizumab epitope-scaffold bound to motavizumab Fab (2011) (0)
- Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 (2020) (0)
- The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions (2017) (0)
- Crystal structure of clade A/E HIV-1 gp120 core in complex with NBD-14010 (2017) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E stran 93TH057 gp120 with LOOP D and Loop V5 from clade A strain KER_2018_11 (2013) (0)
- Crystal structure of multidonor HV6-1-class broadly neutralizing Influenza A antibody 56.a.09 isolated following H5 immunization. (2016) (0)
- Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (2019) (0)
- Crystal structure of 10E8 Fab in complex with a hydrocarbon-stapled HIV-1 gp41 MPER peptide (2014) (0)
- Crystal structure of VRC42.04 Fab in complex with gp41 peptide (2019) (0)
- 2F5 Epitope scaffold ES2 (2010) (0)
- Keynote Speakers - Biographies (2018) (0)
- I-101 Quaternary contact improves the potency of broadly neutralizing antibodies to the CD4-binding site of HIV-1 (2019) (0)
- Crystal structure of antibody 10E8v4-P100fA+P100gA Fab (2021) (0)
- Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 3 Fabs bound, sharpened map (2018) (0)
- Structural basis of HIV-1 gp120 conformational mobility (2009) (0)
- Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom (2017) (0)
- Crystal Structure of P Domain from Norwalk Virus Strain Vietnam 026 in complex with disordered HBGA type Lea (2011) (0)
- Serum recognition of the native trimer and effects of a key mutation in the CD4 binding loop. (2015) (0)
- HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b (2007) (0)
- Novel antibodies with broad neutralizing power of HIV-1 (2011) (0)
- Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies (2019) (0)
- Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen (2020) (0)
- Crystal structure of unliganded HIV-1 clade A/E strain 93TH057 gp120 core (2012) (0)
- Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 02-1F07 Fab. (2017) (0)
- Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer epitope (2004) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120 (2011) (0)
- Structure of freshly purified SARS-CoV-2 S2P spike at pH 7.4 (2021) (0)
- Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom (2019) (0)
- Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGC34 (2021) (0)
- Structure of mouse vaccination-elicited HIV neutralizing antibody vFP5.01 in complex with HIV-1 fusion peptide residue 512-519 (2018) (0)
- Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade AE Strain 93TH057 gp120 Core (2016) (0)
- Structure of SARS-CoV-2 spike at pH 4.5 (2020) (0)
- Crystal Structure of P Domain from Norwalk Virus Strain Vietnam 026 in complex with HBGA type H2 (diglycan) (2011) (0)
- Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity (cid:1) (2010) (0)
- Structure of SARS-CoV-2 spike at pH 4.0 (2020) (0)
- Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET (2019) (0)
- Crystal structure of antibody 10E8v4-P100fA Fab in space group P6422 (2021) (0)
- Automated method for iterative optimization of macromolecular crystallization screens (2017) (0)
- Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold (2019) (0)
- CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike (2021) (0)
- Crystal structure of anti-HIV llama VHH antibody A12 (2012) (0)
- Crystal structure of broadly HIV-1-neutralizing antibody VRC33.01 (2021) (0)
- Crystal Structure of 101F Fab Bound to 17-mer Peptide Epitope (2010) (0)
- Crystal structure of the anti-hiv-1 antibody 2.2c (2014) (0)
- Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses (2022) (0)
- Correction for Ingale et al., Hyperglycosylated Stable Core Immunogens Designed To Present the CD4 Binding Site Are Preferentially Recognized by Broadly Neutralizing Antibodies (2015) (0)
- Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) complexed with CD4 and the X5 antibody (2005) (0)
- Crystal Structure of Broadly Neutralizing Antibody CH04, Isolated from Donor CH0219, in Complex with Scaffolded Trimeric HIV-1 Env V1V2 Domain from the Clade AE Strain A244 (2015) (0)
- Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 (2020) (0)
- Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 (2019) (0)
- Access of antibody molecules to th conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary HIV-1 (2009) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 clade A/E strain 93TH057 gp120 (2015) (0)
- X-ray crystallography and HIV vaccine design (2008) (0)
- 120 Structural Immunology and Vaccine Development (2012) (0)
- Cryo-EM structure of stabilized HIV-1 Env trimer CAP256.wk34.c80 SOSIP.RnS2 (2020) (0)
- Structure of tyrosine-sulfated 412d antibody complexed with HIV-1 YU2 gp120 and CD4 (2007) (0)
- Crystal structure of GII.4 2002 norovirus P domain in complex with neutralizing human antibody A1431 (2019) (0)
- Crystal structure of RV144-elicited antibody CH58 (2013) (0)
- Overview of human plasmas and animal sera. (2015) (0)
- Antibody VRC 01 Structural Basis for Broad and Potent Neutralization of HIV-1 by (2014) (0)
- Structure of the Unliganded Fab from HIV-1 Neutralizing Antibody CAP248-2B that Binds to the gp120 C-terminus - gp41 Interface, at two Angstrom resolution. (2016) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 clade C strain ZM176.66 gp120 (2013) (0)
- Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors (2006) (0)
- Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment (2021) (0)
- CryoEM structure of LILRB1 D3D4 domain-inserted antibody MDB1 Fab in complex with Plasmodium RIFIN (PF3D7_1373400) V2 domain (2021) (0)
- Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields (2019) (0)
- Vaccine-elicited mouse FP-targeting neutralizing antibody vFP49.02 in complex with HIV fusion peptide (residue 512-519) (2021) (0)
- Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 (2020) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 clade A strain KER_2018_11 gp120 (2015) (0)
- Crystal structure of prefusion-stabilized RSV F single-chain 9-10 DS-Cav1 variant. (2016) (0)
- Impact of glycan positioning on HIV-1 Env glycan shield density, function, and antibody recognition (2020) (0)
- Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90 (2016) (0)
- Crystal structure of human anti-HIV-1 gp120-reactive antibody 47e fab (2004) (0)
- Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.3 Angstrom (2020) (0)
- Single-Molecule FRET Reveals an Additional Conformational State of HIV-1 Envelope Glycoprotein Critical for Vaccine Design (2018) (0)
- Crystal structure of ligand-free VRC03 antigen-binding fragment. (2016) (0)
- Vaccine-elicited mouse FP-targeting neutralizing antibody vFP48.03 in complex with HIV fusion peptide (residue 512-519) (2021) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120 (2013) (0)
- Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120 (2015) (0)
- Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain (2021) (0)
- Crystal structure of HIV-1 clade C strain C1086 gp120 core in complex with NBD-556 (2012) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 (2013) (0)
- Vaccine-elicited NHP FP-targeting antibody 13N024-a.01 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221 (2013) (0)
- Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency (2023) (0)
- Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones (2022) (0)
- A Structure-Based Matrix Approach Yields Improved VRC01-Class Antibodies for HIV-1 Therapy and Prevention (2020) (0)
- Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones (2022) (0)
- N123-VRC34_pI3 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 (2020) (0)
- Crystal Structure of the HIV-1 BG505 SOSIP.664 Env Trimer Ectodomain, Comprising Atomic-Level Definition of Pre-Fusion gp120 and gp41, in Complex with Human Antibodies PGT122 and 35O22 (2014) (0)
- Crystal structure of human Fab CAP256-VRC26.25, a potent V1V2-directed HIV-1 broadly neutralizing antibody (2014) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 with LOOP D and Loop V5 from clade A strain 3415_v1_c1 (2013) (0)
- Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced. (2004) (0)
- Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A (2017) (0)
- STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TETRAGONAL CRYSTAL FORM (1997) (0)
- Zinc Acetate / Carrageenan Gel ( PC-1005 ) (2014) (0)
- Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer (2015) (0)
- Cryo-EM Structure of disulfide stabilized HMPV F v4-B (2021) (0)
- Crystal Structure of HIV-1 MI369 RnS-DS.SOSIP Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom (2020) (0)
- Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core (2013) (0)
- Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B. (2019) (0)
- Crystal structure of 10E8 gHV-gLV antigen-binding fragment. (2016) (0)
- C3-Symmetric Aromatic Core of Griffithsin Is Essential for Potent Anti-HIV Activity. (2022) (0)
- Crystal structure of human 2909 Fab, a quaternary structure-specific antibody against HIV-1 (2011) (0)
- D104 Structural definition of new transitional epitopes exposed by CD4 binding to HIV-1 (2013) (0)
- Crystal structure of HIV-1 donor 45 d45-01dG5 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) (2015) (0)
- Crystal structure of prefusion-stabilized bovine RSV fusion glycoprotein (single-chain DS2-v1 variant: strain 391-2 sc9 DS-Cav1 Q98C Q361C) (2017) (0)
- Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists (2022) (0)
- Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain (2017) (0)
- Probing the Conformation and Dynamics of Influenza a M2 Protein using Site-Directed Spin-Label EPR Spectroscopy (2013) (0)
- Crystal Structure of P Domain from Norwalk Virus Strain Vietnam 026 (2011) (0)
- Tryptophan-like side chain holding aptamers inhibit respiratory syncytial virus infection of lung epithelial cells (2023) (0)
- Crystal structure of broadly neutralizing anti-hiv-1 antibody ch103 (2013) (0)
- Protective Antibodies Against Human Parainfluenza Virus Type 3 (HPIV3) Infection (2020) (0)
- Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGD21 (0)
- Crystal structure of GII.4 2002 norovirus P domain in complex with cross-reactive human antibody A1227 (2019) (0)
- Crystal structure of monoclonal anti-CD4 antibody Q425 (2005) (0)
- Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability (2022) (0)
- Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17 (2015) (0)
- Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down (2020) (0)
- Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120 (2015) (0)
- Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide. (2016) (0)
- A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies (2022) (0)
- P-D14 Increasing the Level of Tyrosine Sulfation Alters the Antigenic Profile of the BG505 SOSIP.664 Trimer (2014) (0)
- Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation (2018) (0)
- Correction: Transplanting Supersites of HIV-1 Vulnerability (2014) (0)
- Conformational Changes in HIV-1 Env Trimer Induced by a Single CD4 as Revealed by Cryo-EM (2017) (0)
- Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization (2023) (0)
- Molecular Dissection Of Human Antibody Responses Following Prefusion-Stabilized RSV F Vaccination (2020) (0)
- Crystal Structure of PG9 Fab (2011) (0)
- Crystal Structure of HIV-1 Neutralizing Antibody m66 in complex with gp41 MPER peptide (2014) (0)
- Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Interdomain Stabilization 113C-429GCG in Complex with Broadly Neutralizing Antibodies PGT122 and 35O22 (2018) (0)
- Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.a.26 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin (2016) (0)
- Improving diffraction limits by engineering crystallization chaperones – a case study of HIV1 envelope trimer and its application to drug design (2017) (0)
- Vaccine-elicited murine FP-targeting antibody vFP6.01 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- HIV-1 antibody 2F5 in complex with epitope scaffold ES2 (2010) (0)
- Crystal Structure of Broadly Neutralizing Antibody CH03, Isolated from Donor CH0219, in Complex with Scaffolded Trimeric HIV-1 Env V1V2 Domain from the Clade C Superinfecting Strain of Donor CAP256. (2015) (0)
- Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 (2019) (0)
- Structure of MERS-Coronavirus Spike Receptor-binding Domain (England1 Strain) in Complex with Vaccine-Elicited Murine Neutralizing Antibody D12 (Crystal Form 2) (2015) (0)
- Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22. (2017) (0)
- Vaccine-elicited mouse FP-targeting neutralizing antibody vFP16.02 with S48K mutation in light chain in complex with HIV fusion peptide (residue 512-519) (2021) (0)
- Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with NBD-09027 (2013) (0)
- Crystal structure of broadly and potently neutralizing antibody C38-VRC18.02 in complex with HIV-1 clade AE strain 93TH057gp120 (2015) (0)
- Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom (2019) (0)
- Penetrating the Glycan Shield on HIV‐1 (2015) (0)
- Design clues from functional constraints and broadly neutralizing antibodies (2006) (0)
- P-D3 Crystal structures of small-molecules HIV-1 entry ihibitor, BMS-378806 and BMS-626529, bound to BG505 SOSIP.664 HIV-1 Env trimer reveal an allosteric competitive etry inhibition mechanism (2017) (0)
- Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 (2020) (0)
- Author response: Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core (2018) (0)
- Crystal structure of 10E8v4-5R+100cF Fab in complex with HIV-1 gp41 peptide (2018) (0)
- Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4 (2022) (0)
- Crystal structure of VRC43.03 Fab (2019) (0)
- Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1 (cid:1) †§ (2011) (0)
- Crystal structure of prefusion-stabilized RSV F single-chain 9-10 DS-Cav1 A149C-Y458C, S46G-E92D-S215P-K465Q variant. (2016) (0)
- Crystal Structure of HIV-1 CAP256 RnS-3mut-2G-SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom (2020) (0)
- Vaccine-elicited mouse FP-targeting neutralizing antibody vFP16.02 with F60P mutation on light chain in complex with HIV fusion peptide (residue 512-519) (0)
- Author response: HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations (2018) (0)
- Crystal structure of anti-HIV llama VHH antibody A12 in complex with C186 gp120 (2012) (0)
- Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold (2019) (0)
- Crystal Structure of Respiratory Syncytial Virus Fusion Glycoprotein Stabilized in the Prefusion Conformation by Human Antibody D25 (2013) (0)
- Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA (2021) (0)
- Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike (0)
- Vaccine-elicited murine FP-targeting antibody vFP25.18 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- P09-13. Structure of HIV-1 gp41 interactive region: layered architecture and basis of conformational mobility (2009) (0)
- 101 Chemokine Receptor CCR5 Mediates Resistance to West Nile Virus Infection in Mouse and Man (2009) (0)
- Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs (2021) (0)
- The 447-52D Antibody: Hitting HIV-1 (2004) (0)
- crystal structure of broadly neutralizing antibody CH103 in complex with HIV-1 gp120 (2013) (0)
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (2019) (0)
- Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination (2022) (0)
- Disulfide Stabilized Norovirus GI.1 VLP Shell Region (2020) (0)
- Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab (2016) (0)
- Commentary The changing face of HIV vaccine research (2012) (0)
- HIV-1 Infection Response Implicated in Reduced Risk for Antibody-Dependent Cellular Cytotoxicity Structural Definition of an (2014) (0)
- Crystallography and HIV-1 vaccine design (2011) (0)
- Vaccine-elicited NHP FP-targeting HIV neutralizing antibody A12V163-a.01 in complex with HIV fusion peptide (residue 512-519) (2019) (0)
- Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope. (2023) (0)
- Antibodiesand Their Recognition by Immunotypes of a Quaternary Site of HIV-1 (2014) (0)
- Crystal structure of antibody 10E8v4 Fab - light chain H31F variant (2021) (0)
- Crystal structure of LAIR1 ectodomain (from MGD21) in complex with Plasmodium RIFIN (PF3D7_0401300) V2 domain (0)
- HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b (2007) (0)
- CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike (2021) (0)
- Vaccine-elicited NHP FP-targeting HIV neutralizing antibody DFPH-a.15 in complex with HIV fusion peptide (residue 512-519) (2019) (0)
- Transient Protein Expression Facilitates X-ray Structural Studies of HIV-1 (2014) (0)
- Crystal Structure of HIV-1 Neutralizing Antibody m66.6 (2011) (0)
- Vaccine-elicited NHP FP-targeting neutralizing antibody DF2F-b.04 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120 (2013) (0)
- Cryo-EM Structure of Vaccine-Elicited Rhesus Antibody 789-203-3C12 in Complex with Stabilized SI06 (A/Solomon Islands/3/06) Influenza Hemagglutinin Trimer (2021) (0)
- How Computational and Structural Biology Are Changing Vaccine Design (2015) (0)
- Structure of aged SARS-CoV-2 S2P spike at pH 7.4 (2021) (0)
- Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down) (2020) (0)
- , In Vivo Infection Improves Protection against Lentiviral In Vitro Neutralizing HIV-1 Antibody Enhanced Potency of a Broadly (2014) (0)
- Crystal structure of antibody VRC07-I30Q, G54W, S58N in complex with clade A/E 93TH057 HIV-1 gp120 core (2014) (0)
- Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 HA trimer (2021) (0)
- Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 (2020) (0)
- Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 (2019) (0)
- Protein Local Structure Prediction Using Support Vector Machine (2010) (0)
- Conformational Dynamics of Single HIV-1 Envelope Proteins on the Surface of Native Virions (2015) (0)
- Vaccine-elicited NHP FP-targeting antibody 0PV-a.04 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- Crystal structure of LILRB1 D3D4 domain in complex with Plasmodium RIFIN (PF3D7_1373400) V2 domain (2021) (0)
- HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b (2007) (0)
- Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses (2021) (0)
- Crystal structure of monoclonal anti-CD4 antibody Q425 in complex with Calcium (2005) (0)
- Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins (2022) (0)
- Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2 (2020) (0)
- Crystal structure of the anti-hiv-1 antibody 2.2c in complex with hiv-1 93ug037 gp120 (2014) (0)
- Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with MAE-II-167 (2013) (0)
- Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 (2018) (0)
- Crystal Structure of Motavizumab Fab Bound to Peptide Epitope (2010) (0)
- Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to VRC01 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.5 Angstrom (2019) (0)
- Interactions of the CD4 and CD8 T-cell co-receptors in the cellular immune response (1993) (0)
- Crystal structure of [Phe23]M47, a scorpion-toxin mimic of CD4, in complex with HIV-1 YU2 GP120 envelope glycoprotein and anti-HIV-1 antibody 17B (2005) (0)
- An intact amber-free HIV-1 system for in-virus protein bioorthogonal click labeling that delineates envelope conformational dynamics (2023) (0)
- HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 (2007) (0)
- PROTECTIVE ANTIBODIES AGAINST HPIV3 INFECTION (2020) (0)
- Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2411a in complex with HIV-1 gp120 core (2021) (0)
- Applications of high-throughput single B-cell sequencing to accelerate rational vaccine design (2016) (0)
- Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) (2015) (0)
- Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.09 in complex with HIV-1 clade A/E 93TH057 gp120 (2016) (0)
- Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 (2019) (0)
- Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1 (2020) (0)
- GLYCO: a tool to quantify glycan shielding of glycosylated proteins (2021) (0)
- Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes (2020) (0)
- Structure of MERS-Coronavirus Spike Receptor-binding Domain (England1 Strain) in Complex with Vaccine-Elicited Murine Neutralizing Antibody D12 (Crystal Form 1) (2015) (0)
- Hiv-1 env fusion peptide immunogens and their use (2017) (0)
- McLellan Respiratory Syncytial Virus Structure-Based Design of a Fusion Glycoprotein Vaccine for (2014) (0)
- 2F5 Epitope scaffold elicited anti-HIV-1 monoclonal antibody 11F10 in complex with HIV-1 GP41 (2010) (0)
- Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens (2022) (0)
- Crystal structure of antibody 10E8v4-P100fA Fab in space group C2 (2021) (0)
- ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4 (2020) (0)
- N123-VRC34_pI4 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 (2020) (0)
- Venom protection by broadly neutralizing antibody from a snakebite subject (2023) (0)
- Crystal structure of vaccine-elicited pan- influenza H1N1 neutralizing murine antibody 441D6. (2018) (0)
- Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide (2013) (0)
- Crystal Structure at 3.4 A Resolution of Fully Glycosylated HIV-1 Clade G X1193.c1 SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122, 35O22 and VRC01 (2016) (0)
- Crystal structure of prefusion-stabilized RSV F single-chain 9-10 DS-Cav1 A149C-Y458C variant. (2016) (0)
- Crystal structure of fully glycosylated HIV-1 gp120 core bound to CD4 and 17b Fab (2014) (0)
- Crystal Structure of HIV-1 Clade A BG505 Fusion Peptide (residue 512-520) in Complex with Broadly Neutralizing Antibody VRC34.01 Fab (2016) (0)
- HIV-1 V 1 V 2 antibody with exceptional potency 5 6 (2015) (0)
- Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120 (2013) (0)
- Crystal Structure of HIV-1 Clade AE Strain CNE55 gp120 Core in Complex with Neutralizing Antibody VRC-PG05 that Targets the Center of the Silent Face on the Outer Domain of gp120 (2018) (0)
- Structure of HIV-1 gp120 (core with V3) in Complex with CD4-Binding-Site Antibody F105 (2009) (0)
- Crystal Structure of Neutralizing Antibody HJ16 in Complex with HIV-1 gp120 (2015) (0)
- Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography (2021) (0)
- Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection (2015) (0)
- Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2413a in complex with HIV-1 gp120 core (2021) (0)
- Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike (2021) (0)
- Crystal Structure of RSV strain B18537 Prefusion-stabilized glycoprotein F Variant DS-Cav1 (2020) (0)
- HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b (2007) (0)
- Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2 (2022) (0)
- STRUCTURE OF THE MONOCLINIC C2 FORM OF HEN EGG-WHITE LYSOZYME AT 2.0 ANGSTROMS RESOLUTION (2003) (0)
- HumanImmunodeficiency VirusType2Infection andFusionof CD4-Negative HumanCellLines: Induction and Enhancement bySoluble CD4 (1992) (0)
- McDonald and colleagues reply (1993) (0)
- Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174 (2018) (0)
- HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b (2007) (0)
- Vaccine-elicited NHP FP-targeting antibody DF2F-e.01 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- Crystal structure of broadly HIV-1-neutralizing antibody VRC40.01 (2021) (0)
- Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 2 Fabs bound, sharpened map (2018) (0)
- Crystal Structure of HIV-1 ConC_Base0 Prefusion Env Trimer in Complex with Human Antibody Fragment 3H109L and 35O22 variants at 3.5 Angstrom (2018) (0)
- Crystal Structure of Broadly Neutralizing HIV-1 Fusion Peptide-Targeting Antibody VRC34.01 Fab (2016) (0)
- Quantitative, molecular-level analysis of the serum antibody repertoire reveals unanticipated features of the response to seasonal influenza vaccination (2016) (0)
- Crystal structure of YU2 gp120 core in complex with Fab 48d and NBD-557 (2013) (0)
- Structure of unbound MERS-CoV spike receptor-binding domain (England1 strain). (2015) (0)
- Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain (2021) (0)
- Crystal structure of VRC03 gHVgLV antigen-binding fragment. (2016) (0)
- Crystal structure of the anti-HIV b12 scaffold protein (2011) (0)
- Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-c.01 in complex with FP (residue 512-519) (2019) (0)
- Crystal structure of broadly neutralizing Influenza A antibody 31.a.83 in complex with Hemagglutinin Hong Kong 1968. (2017) (0)
- Crystal structure of broadly and potently neutralizing antibody 3bnc117 in complex with hiv-1 gp120 (2013) (0)
- P-D11 Structural basis for ADCC to A32-like region (2014) (0)
- Structure of NCI09 fab in complex with SIV V2 peptide (2020) (0)
- Crystal Structure of Prefusion-stabilized RSV F Variant DS-Cav1-TriC at pH 9.5 (2013) (0)
- Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 (2019) (0)
- 55th Annual Rocky Mountain Conference on Magnetic Resonance (2019) (0)
- Crystal Structure of P Domain from Norwalk Virus Strain Vietnam 026 in complex with HBGA type Ley (2011) (0)
- Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom (2019) (0)
- Vaccine-elicited NHP FP-targeting antibody DF2F-a.01 in complex with HIV fusion peptide (residue 512-519) (2020) (0)
- Improvement of antibody functionality by structure-guided paratope engraftment (2019) (0)
- Crystal structure of HIV-1 gp120 core in complex with NBD-11021, a small molecule CD4-antagonist (2015) (0)
- Crystal structure of unliganded HIV-1 clade C strain C1086 gp120 core (2012) (0)
- Crystal structure of antibody 10E8v4-P100gA Fab (2021) (0)
- Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with CD4 and antibody PGT145 (2017) (0)
- Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan. (2016) (0)
- Protection of calves by a prefusion-stabilized bovine RSV F vaccine (2017) (0)
- Crystal structure of broadly and potently neutralizing antibody 12a21 in complex with hiv-1 strain 93th057 gp120 mutant (2013) (0)
- Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC134 in complex with HIV-1 clade A Q842.d12 gp120 (2015) (0)
- CHAPTER 17 – HIV-1 Receptor Interactions (2003) (0)
- Crystal structure of Middle-East Respiratory Syndrome (MERS) coronavirus neutralizing antibody JC57-14 isolated from a vaccinated rhesus macaque in complex with MERS Receptor Binding Domain (2018) (0)
- Crystal structure of CD4-mimetic miniprotein M48U12 in complex with HIV-1 YU2 gp120 (2013) (0)
- Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with NBD-10007 (2013) (0)
- Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-b.01 in complex with HIV fusion peptide (residue 512-519) (2019) (0)
- Interactions between Anti-HIV Antibodies and their Lipid-Embedded Epitopes Defined by EPR Spectroscopy (2013) (0)
- D107 Effective CD4-binding-site antibodies: Atomic-level structures and ontogenies (2013) (0)
- Crystal structure of unliganded HIV-1 clade C strain ZM109F.PB4 gp120 core (2012) (0)
- Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node. (2023) (0)
- HIV-1 Env structure and vaccine design (2014) (0)
- Crystal structure of 10E8 gHV-matureL antigen-binding fragment. (2016) (0)
- Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer (2021) (0)
- Crystal structure of CD4-mimetic miniprotein M48U1 in complex with HIV-1 YU2 gp120 in P212121 space group (2013) (0)
- Crystal Structure of P Domain from Norwalk Virus Strain Vietnam 026 in complex with HBGA type H2 (triglycan) (2011) (0)
- Crystal structure of VRC43.01 Fab (2019) (0)
- Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with TS-II-224 (2012) (0)
- Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-a.01 in complex with FP (residue 512-519) (2019) (0)
- Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009 (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter D. Kwong?
Peter D. Kwong is affiliated with the following schools:
